Skip to main content
Have a personal or library account? Click to login
Tumor ablation: emerging uses, challenges, and strategic implementation. A green paper by the Network of Expertise in Cancer (JANE-2), High Tech Medical Resources, network on Physical Methods of Tumor Ablation Cover

Tumor ablation: emerging uses, challenges, and strategic implementation. A green paper by the Network of Expertise in Cancer (JANE-2), High Tech Medical Resources, network on Physical Methods of Tumor Ablation

Open Access
|Jun 2026

Figures & Tables

FIGURE 1.

Use of ablative therapies according to the organs treated and technologies used.

FIGURE 2.

Schematic and graphical presentation of the aims of the Physical Methods of Ablation Domain of the JANE-2 project, which are discussed in this review for broader application of ablative therapies in treatment of cancer throughout Europe.

FIGURE 3.

Envisioned development and integration of physical methods of ablation into cancer care paths.

Common ablative therapies in oncology with a brief description of their mode of action, common applications, advantages and disadvantages_ Most of them are considered thermal ablations, except for irreversible electroporation and electrochemotherapy

Ablative therapyMode of actionCommon applicationsAdvantagesDisadvantages
Radiofrequency ablation (RFA)High-frequency alternating current generates heat, causing irreversible coagulative necrosis through protein denaturationLiver, kidney, lung and bone tumorsMinimally invasive, widely available, effective for small tumorsLimited effectiveness near large blood vessels (heat sink effect), not ideal for cystic tumors. Extent of ablation area not visible in real time
Microwave ablation (MWA)Electromagnetic waves agitate water molecules, generating heat and inducing irreversible coagulative necrosisLiver, kidney lung and bone tumorsFaster and larger ablation zones than RFA, less affected by heat sinkRisk of overheating nearby critical tissues. Extent of ablation area not visible in real time
Cryoablation (Cryo)Freezing and thawing causes ice crystal formation and cell rupture leading to coagulative necrosisProstate, kidney, bone, desmoid and lung tumorsGood real time visualization of ablation area with imaging, less pain post-procedureLonger procedure time, risk of cryo-shock in liver ablation, costs
Laser ablationConcentrated light energy heats and destroys target tissue by coagulative necrosisBrain tumors, liver metastases, dermatologyPrecise and controllable,Very limited penetration
Irreversible electroporation (IRE)Electric pulses create permanent nanopores in cell membranes, inducing apoptosisTumors near critical structures (e.g., bile ducts in liver, pancreas, prostate)Non-thermal, spares connective tissue and vesselsLonger procedure time and general anesthesia recommended
Electrochemotherapy (ECT)Electric pulses increase cell membrane permeability, enhancing drug uptake, leading to different types of cell death depending on the concentration of the drugCutaneous, subcutaneous, mucosal and deep-seated tumors, potentially pancreatic cancerHighly effective for superficial tumors, low systemic toxicity, spares connective tissue and vesselsBimodal treatment, drug and application of pulsed electric field
DOI: https://doi.org/10.2478/raon-2026-0030 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 153 - 165
Submitted on: May 4, 2026
Accepted on: May 11, 2026
Published on: Jun 26, 2026
In partnership with: Paradigm Publishing Services

© 2026 Julie Gehl, Philippe L Pereira, Colin P Cantwell, Frédéric Deschamps, Anja Kocijancic, Nina Schmidt, Rok Dezman, Greta Chlebopasevienė, Andrei Roman, Maja Cemazar, Gregor Sersa, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.